Annexon Bioscience Receives $34,000,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=babe42c9-231a-4b3b-873a-30a90ccade03 - Date
12/16/2014 - Company Name
Annexon Bioscience - Mailing Address
Undisclosed Redwood City, CA 94062 USA - Company Description
Annexon is developing novel therapeutics for neurodegenerative and autoimmune disorders. We have discovered that early components of the classical complement cascade accumulate on synapses with normal aging and are activated as the brain encounters stress or disease to cause loss of nerve connections. - Website
http://www.annexonbio.com - Transaction Type
Venture Equity - Transaction Amount
$34,000,000 - Transaction Round
Series A - Proceeds Purposes
The company intends to use the funds for the development of its lead candidate, ANX005, for the treatment of neurodegenerative and autoimmune disorders. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
